State Street Corp Sells 33,324 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

State Street Corp trimmed its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 3.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 904,901 shares of the company’s stock after selling 33,324 shares during the period. State Street Corp owned 2.23% of Phibro Animal Health worth $20,378,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of PAHC. Jacobs Levy Equity Management Inc. raised its holdings in Phibro Animal Health by 116.6% during the third quarter. Jacobs Levy Equity Management Inc. now owns 192,255 shares of the company’s stock valued at $4,330,000 after acquiring an additional 103,491 shares during the period. BNP Paribas Financial Markets raised its stake in Phibro Animal Health by 3.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after purchasing an additional 729 shares during the period. Quantbot Technologies LP purchased a new position in Phibro Animal Health in the 3rd quarter worth approximately $70,000. FMR LLC boosted its stake in Phibro Animal Health by 22.7% in the 3rd quarter. FMR LLC now owns 39,310 shares of the company’s stock worth $885,000 after purchasing an additional 7,270 shares during the period. Finally, Algert Global LLC grew its holdings in Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after buying an additional 59,850 shares in the last quarter. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Trading Down 0.2 %

Shares of NASDAQ PAHC opened at $21.64 on Tuesday. Phibro Animal Health Co. has a 1-year low of $10.03 and a 1-year high of $25.98. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The business’s 50 day moving average is $23.52 and its two-hundred day moving average is $20.77. The stock has a market capitalization of $876.48 million, a P/E ratio of 50.33, a PEG ratio of 0.58 and a beta of 0.51.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were issued a dividend of $0.12 per share. The ex-dividend date was Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.22%. Phibro Animal Health’s payout ratio is presently 111.63%.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the stock. Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. StockNews.com upgraded Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, December 18th. Bank of America boosted their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th. JPMorgan Chase & Co. began coverage on Phibro Animal Health in a report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price target for the company. Finally, Barclays upped their price objective on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a report on Tuesday, November 12th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a strong buy rating to the company. Based on data from MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and a consensus price target of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.